Tissue engineering and regenerative medicine as applied to the gastrointestinal tract
- PMID: 23583170
- PMCID: PMC3723710
- DOI: 10.1016/j.copbio.2013.03.021
Tissue engineering and regenerative medicine as applied to the gastrointestinal tract
Abstract
The gastrointestinal (GI) tract is a complex system characterized by multiple cell types with a determined architectural arrangement. Tissue engineering of the GI tract aims to reinstate the architecture and function of all structural layers. The key point for successful tissue regeneration includes the use of cells/biomaterials that elucidate minimal immune response after implantation. Different biomaterial choices and cell sources have been proposed to engineer the GI tract. This review summarizes the recent advances in bioengineering the GI tract with emphasis on cell sources and scaffolding biomaterials.
Copyright © 2013 Elsevier Ltd. All rights reserved.
References
-
- Levitt MA, Dickie B, Pena A. Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure. Semin Pediatr Surg. 2010;19:146–153. - PubMed
-
- Beyer-Berjot L, Joly F, Maggiori L, Corcos O, Bouhnik Y, Bretagnol F, Panis Y. Segmental reversal of the small bowel can end permanent parenteral nutrition dependency: an experience of 38 adults with short bowel syndrome. Ann Surg. 2012;256:739–745. - PubMed
-
- Sampietro GM, Corsi F, Maconi G, Ardizzone S, Frontali A, Corona A, Porro GB, Foschi D. Prospective study of long-term results and prognostic factors after conservative surgery for small bowel Crohn's disease. Clin Gastroenterol Hepatol. 2009;7:183–191. quiz 125. - PubMed
-
- Braghetto I, Korn O, Valladares H, Debandi A, Diaz JC, Brunet L. Laparoscopic surgical treatment for patients with short- and long-segment Barrett's esophagus: which technique in which patient? Int Surg. 2011;96:95–103. - PubMed
-
- Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–449. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
